APA (7th ed.) Citation

Wynn, J., Rego, S., Brown, D., Talati, A., Zaretsky, M., & Trimble, A. (2024). 378 Routine cell-free DNA prenatal screening identifies pregnancies at high-risk for cystic fibrosis that may benefit from fetal therapy. Journal of Cystic Fibrosis, 23, S196. https://doi.org/10.1016/S1569-1993(24)01218-9

Chicago Style (17th ed.) Citation

Wynn, J., S. Rego, D. Brown, A.N Talati, M. Zaretsky, and A. Trimble. "378 Routine Cell-free DNA Prenatal Screening Identifies Pregnancies at High-risk for Cystic Fibrosis That May Benefit from Fetal Therapy." Journal of Cystic Fibrosis 23 (2024): S196. https://doi.org/10.1016/S1569-1993(24)01218-9.

MLA (9th ed.) Citation

Wynn, J., et al. "378 Routine Cell-free DNA Prenatal Screening Identifies Pregnancies at High-risk for Cystic Fibrosis That May Benefit from Fetal Therapy." Journal of Cystic Fibrosis, vol. 23, 2024, p. S196, https://doi.org/10.1016/S1569-1993(24)01218-9.